Premium
CA 125, CA 15.3, CA 27.29, CEA, β‐hCG and α‐fetoprotein levels in cyst fluid of breast macrocysts
Author(s) -
Martínez L.,
Castilla J.A.,
Blanco N.,
Perán F.,
Herruzo A.
Publication year - 1995
Publication title -
international journal of gynecology and obstetrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.895
H-Index - 97
eISSN - 1879-3479
pISSN - 0020-7292
DOI - 10.1016/0020-7292(94)02279-8
Subject(s) - fibrocystic breast disease , cyst , medicine , alpha fetoprotein , endocrinology , pathology , gynecology , gastroenterology , breast cancer , cancer , hepatocellular carcinoma
Objective: To determine the tumoral markers CA 125, CA 15.3, CA 27.29, CEA, β‐hCG and α‐fetoprotein in serum and breast cystic fluid in women with fibrocystic breast disease. Methods: The study comprised 50 women diagnosed with fibrocystic breast disease but without breast macrocysts, and 60 women with macrocysts. Results: Significantly higher levels of CA 125, CA 27.29, β‐hCG and CEA were observed in the cyst fluid than in the serum of the same patients. According to their K + /Na + quotient we found that when K + /Na + was <3, cyst fluid CA 125, CA 27.29, β‐hCG and CEA levels were significantly higher than serum levels. However, when K + /Na + was >3, only CA 27.29 and β‐hCG levels were significantly higher. Comparing cyst fluid marker levels with respect to the K + /Na + ratio, the only difference observed was in CA 125 which was significantly greater when K + /Na + was < 3. A negative correlation was found between CA 125 and the K + /Na + quotient. Conclusion: These results suggest that CA 125 could be used as a marker to identify cyst type.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom